Common Side Effects of Artesunate
Artesunate, an antimalarial drug, often causes mild to moderate reactions that resolve after treatment ends. These include headache, dizziness, nausea, vomiting, fatigue, and muscle or joint pain. Fever, chills, and loss of appetite also occur frequently during initial doses.[1][2]
Serious Side Effects and Risks
Rare but severe effects include hemolytic anemia (red blood cell breakdown, sometimes delayed up to a month post-treatment), liver enzyme elevations, and allergic reactions like rash or anaphylaxis. Cardiac issues such as bradycardia or QT prolongation have been reported, particularly with IV use. Post-artemisinin delayed hemolysis (PADH) affects about 7% of severe malaria patients treated with IV artesunate.[3][4]
Side Effects in Special Populations
Pregnant women may face risks like fetal distress or miscarriage with high doses, though it's recommended for severe malaria in the second/third trimesters by WHO. Children experience similar effects but with higher rates of anemia. Long-term use raises concerns for neurotoxicity in animal studies, though human data is limited.[2][5]
How Side Effects Compare to Other Antimalarials
Artesunate has a better safety profile than quinine (fewer hypoglycemic events) but similar cardiac risks to chloroquine. Compared to artemether-lumefantrine combinations, it shows higher hemolysis rates in IV form.[1][3]
Monitoring and Management
Doctors monitor blood counts weekly for 4 weeks post-IV treatment to catch delayed hemolysis. Most effects are dose-dependent and short-lived; supportive care like hydration helps. Report persistent symptoms immediately.[4][5]
[1]: CDC - Artesunate
[2]: WHO Guidelines for Malaria Treatment
[3]: NEJM - Post-Artesunate Delayed Hemolysis
[4]: FDA - Artesunate Labeling
[5]: PubMed - Safety Review of Artemisinin Derivatives